JANICE DELGIORNO: Open Payments
NPI 1669645032 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 11 payments from 7 companies in 2025. Trend: 2023 $521 · 2024 $531 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 4 | $168 |
| GENZYME CORPORATION | 1 | $146 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $140 |
| Novo Nordisk Inc | 1 | $99 |
| Integra LifeSciences Corporation | 1 | $21 |
| Smith+Nephew, Inc. | 1 | $17 |
| Boston Scientific Corporation | 1 | $14 |
Products named: ULTOMIRIS, DUPIXENT, JOURNAVX, Ozempic, Integra, COLLAGENASE SANTYL, WaveWriter Alpha Prime 16.
Industry payments across NJ — which companies pay providers there.
